查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
分子诊断的全球市场:市场规模，市场占有率，趋势分析，机会，预测:各产品，各技术，各终端用户，各用途，各地区(2018年～2028年)
市场调查报告书
商品编码
1147293

分子诊断的全球市场:市场规模，市场占有率，趋势分析，机会，预测:各产品，各技术，各终端用户，各用途，各地区(2018年～2028年)

Molecular Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented By Product ; By Technology ; By End User ; By Application ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 410 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球分子诊断的市场规模，从2021年的165亿1,000万美元预计到2028年达到394亿美元，在预测期间(2022年～2028年)以11.3％的年复合成长率成长。分子诊断的技术开拓发展，在新兴国家的疾病早期诊断的认识高涨，促进分子诊断市场成长。

本报告提供全球分子诊断市场的相关调查，市场概要，市场分析，企业简介等全面性资讯。

目录

第1章 调查架构

第2章 摘要整理

第3章 全球分子诊断市场洞察

  • 产业价值链分析
  • DROC分析
    • 促进因素
      • 感染疾病和癌症的盛行率增加
      • 检验成本的削减和调查活动增加
      • 对一般社会的认识度提高
    • 阻碍因素
      • 由于缺乏恰当的计费指南的不利偿付
      • 其他
    • 机会
      • 新兴国家的成长机会
      • 遗传基因检验的需求高涨
      • 其他
    • 课题
      • 严格的法律规范
      • 替代技术的简介
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 新加入业者的威胁
    • 替代品的威胁
    • 竞争的激烈程度

第4章 全球分子诊断市场概要

  • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
      • 设备
      • 试剂
      • 其他
    • 各技术
      • 聚合酵素链锁反应(PCR)
      • 杂合反应
      • DNA定序
      • 微阵列
      • 恆温核酸增幅技术(INAAT)
      • 其他
    • 各终端用户
      • 诊断检验室
      • 医院和诊所
      • 研究机关
      • 其他
    • 各用途
      • 传染病检查
      • 肿瘤检验
      • 药物基因体学
      • 遗传基因检验
      • 血液筛检
      • 神经疾病
      • 循环系统疾病检验
      • 微生物检验
      • 其他
    • 各地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东及非洲

第5章 北美的分子诊断市场

    • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
    • 各技术
    • 各终端用户
    • 各用途
    • 各国
      • 美国
      • 加拿大

第6章 欧洲的分子诊断药市场

  • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
    • 各技术
    • 各终端用户
    • 各用途
    • 各国
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 荷兰
      • 比利时
      • 北欧各国
      • 其他欧洲

第7章 亚太地区的分子诊断市场

  • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
    • 各技术
    • 各终端用户
    • 各用途
    • 各国
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲和纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 菲律宾
      • 越南
      • 其他亚太地区

第8章 南美的分子诊断市场

  • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
    • 各技术
    • 各终端用户
    • 各用途
    • 各国
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 哥伦比亚
      • 其他南美国家

第9章 中东及非洲的分子诊断市场

  • 市场规模与预测(2018年～2028年):各金额
    • 各金额(10亿美元)
  • 市场占有率与预测
    • 各产品
    • 各技术
    • 各终端用户
    • 各用途
    • 各国
      • 沙乌地阿拉伯
      • 阿拉伯联合大公国
      • 卡达
      • 科威特
      • 伊朗
      • 南非
      • 奈及利亚
      • 肯亚
      • 埃及
      • 摩洛哥
      • 阿尔及利亚
      • 其他中东

第10章 竞争情形

  • 主要企业与其产品的清单
  • 企业的市场占有率分析(2021年)
  • 竞争基准:各操作参数
  • 主要的策略性展开(合併，收购，伙伴关係等)

第11章 COVID-19对全球分子诊断市场产业的影响

第12章 企业简介(企业概要，财务矩阵，竞争情形，主要的人员，主要的竞争，联络原住所，策略性展望)

  • ABOTT LABORATORIES
  • Agilent Technologies Inc.
  • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • HOFFMON LA-ROCHE LTD
  • GRIFOLS S.A.
  • HOLOGIC INC.
  • QIAGEN INC
  • SIEMENS AG
  • 其他

第13章 主要策略性推荐事项

第14章 调查手法

简介目录
Product Code: BWC20325

Global Molecular Diagnostics Market Flourishing at Robust 11.3% CAGR during Forecast Period

The global molecular diagnostics market is thriving because of rising technological developments in molecular diagnostics and a growing awareness of early disease diagnosis in emerging nations are driving market expansion.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global molecular diagnostics market at USD 16.51 billion in 2021. During the forecast period between 2022 and 2028, the size of global molecular diagnostics market is projected to grow at a CAGR of 11.3%, to reach a value of USD 39.4 billion by 2028. Global outbreaks of severe infectious diseases caused by pathogenic microorganisms have posed a huge threat to public health around the world, motivating researchers to create speedy and effective pathogen detection technologies. Traditionally, culture-based pathogen detection techniques have been considered gold standards. However, the significant turnaround time associated with these procedures, due to overnight culturing and pathogen isolation, limits their use. The invention and implementation of molecular diagnostic tools have ushered in a revolution in the diagnosis and surveillance of infectious diseases in recent years.

Global Molecular Diagnostics Market - Overview

Cellular-Molecular diagnostics is a broad term that refers to a group of diagnostic tests that examine a person's health on a cellular and molecular level, detecting and measuring specific cellular alterations, genetic sequences in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), amino acids, and the proteins they express. The recent advancements in diagnostics such as PCR have gained popularity in recent years due to detection of infectious diseases and genetic modifications. This works by identifying the pathogenic DNA/RNA or abnormalities in cell culture. Molecular diagnostics work efficiently in producing highly accurate results. Furthermore, diagnostic companies have adopted advanced technologies like Artificial Intelligence to render products and services that could produce results in minimal duration with precision.

Impact of COVID-19 on Global Molecular Diagnostics Market

Coronavirus disease (COVID-19) is an extremely contagious illness. The COVID-19 virus causes mild to moderate respiratory disease in those who are infected. In December 2019, the COVID-19 strain was discovered in Wuhan, Hubei Province, China. It has since spread to various countries throughout the world, prompting the WHO to declare it a pandemic. COVID-19 molecular diagnostic testing has proven critical in the global response to the epidemic. Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods since testing remains a critical step in preventing the disease's rapid spread. As a result, regulatory agencies used techniques to expedite the licensing of molecular diagnostic products.

Corporations have made strategic investments to adopt COVID-19 quick tests and reduce the impact of COVID-19 on their operating capabilities. Diagnostic testing continues to be the backbone of the COVID-19 response, enabling containment and mitigation activities. The severity of the crisis as well as the growing capacity issues associated with PCR-based testing pushed the development of diagnostic solutions to fulfill the demand for mass testing. COVID-19 testing and tracking procedures were built up by major players in the market. Various profiling methods, such as PCR testing panels and medicines, were approved by the FDA for emergency use in COVID-19 testing and diagnostics. Such advancements could drive global molecular diagnostics market.

Global Molecular Diagnostics Market - Regional Analysis

Developing economies, such as India, China, Brazil, Turkey, and South Africa could drive global molecular diagnostics market, as these countries' high disease prevalence, big patient population, expanding healthcare infrastructure, rising disposable income, and growing medical tourism. In addition to the above-mentioned characteristics, Asia Pacific has developed as a flexible and business-friendly center due to its tax regulatory and data requirements.

Competitive Landscape

The global market for molecular diagnostics is fiercely competitive with a number of prominent players. Mid-sized to small businesses, on the other hand, are expanding their market presence by releasing new devices at lower rates, all thanks to technical improvements and product innovations. Key companies in global molecular diagnostics market include Abbott Laboratories, F Hoffmann-la Roche Ltd, Hologic Corporation, Danaher Corporation, and Agilent Technology.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Molecular Diagnostics Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Molecular Diagnostics Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Type Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Molecular Diagnostics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Prevalence of Infectious Diseases & Cancer
      • 3.2.1.2. Increasing Research Activities Set to Bring Down Cost of Testing and Boost Market Growth
      • 3.2.1.3. Increasing Awareness in General Public is a Great Opportunity for Market Expansion
    • 3.2.2. Restraints
      • 3.2.2.1. Unfavorable Reimbursement Due to Lack of Proper Billing Guidelines in Different Regions
      • 3.2.2.2. Others
    • 3.2.3. Opportunity
      • 3.2.3.1. Growth Opportunities in Emerging Economies
      • 3.2.3.2. Rising demand for genetic tests is a big opportunity for global molecular diagnostics market
      • 3.2.3.3. Others
    • 3.2.4. Challenges
      • 3.2.4.1. Strict Regulatory Framework
      • 3.2.4.2. Introduction of Alternative Technologies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of New Entrants
    • 3.3.4. Threat of Substitutes
    • 3.3.5. Intensity of Rivalry

4. Global Molecular Diagnostics Market Overview

  • 4.1. Market Size & Forecast by Value, 2018-2028
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Instruments
      • 4.2.1.2. Reagents
      • 4.2.1.3. Others
    • 4.2.2. By Technology
      • 4.2.2.1. Polymerase Chain Reaction (PCR)
      • 4.2.2.2. Hybridization
      • 4.2.2.3. DNA Sequencing
      • 4.2.2.4. Microarray
      • 4.2.2.5. Isothermic Nucleic Acid Amplification Technology (INAAT)
      • 4.2.2.6. Others
    • 4.2.3. By End User
      • 4.2.3.1. Diagnostic Laboratories
      • 4.2.3.2. Hospitals & Clinics
      • 4.2.3.3. Research Institutions
      • 4.2.3.4. Others
    • 4.2.4. By Application
      • 4.2.4.1. Infectious Disease
      • 4.2.4.2. Oncology
      • 4.2.4.3. Pharmacogenomics
      • 4.2.4.4. Genetic Testing
      • 4.2.4.5. Blood Screening
      • 4.2.4.6. Neurological Disease
      • 4.2.4.7. Cardiovascular Disease
      • 4.2.4.8. Microbiology
      • 4.2.4.9. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia Pacific
      • 4.2.5.4. Latin America
      • 4.2.5.5. Middle East and Africa

5. North America Molecular Diagnostics Market

    • 5.1.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.2. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Technology
    • 5.2.3. By End User
    • 5.2.4. By Application
    • 5.2.5. By Country
      • 5.2.5.1. United States
      • 5.2.5.1.1. By Product
      • 5.2.5.1.2. By Technology
      • 5.2.5.1.3. By End User
      • 5.2.5.1.4. By Application
      • 5.2.5.2. Canada
      • 5.2.5.2.1. By Product
      • 5.2.5.2.2. By Technology
      • 5.2.5.2.3. By End User
      • 5.2.5.2.4. By Application

6. Europe Molecular Diagnostics Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By End User
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. Germany
      • 6.2.5.1.1. By Product
      • 6.2.5.1.2. By Technology
      • 6.2.5.1.3. By End User
      • 6.2.5.1.4. By Application
      • 6.2.5.2. United Kingdom
      • 6.2.5.2.1. By Product
      • 6.2.5.2.2. By Technology
      • 6.2.5.2.3. By End User
      • 6.2.5.2.4. By Application
      • 6.2.5.3. Italy
      • 6.2.5.3.1. By Product
      • 6.2.5.3.2. By Technology
      • 6.2.5.3.3. By End User
      • 6.2.5.3.4. By Application
      • 6.2.5.4. France
      • 6.2.5.4.1. By Product
      • 6.2.5.4.2. By Technology
      • 6.2.5.4.3. By End User
      • 6.2.5.4.4. By Application
      • 6.2.5.5. Spain
      • 6.2.5.5.1. By Product
      • 6.2.5.5.2. By Technology
      • 6.2.5.5.3. By End User
      • 6.2.5.5.4. By Application
      • 6.2.5.6. The Netherlands
      • 6.2.5.6.1. By Product
      • 6.2.5.6.2. By Technology
      • 6.2.5.6.3. By End User
      • 6.2.5.6.4. By Application
      • 6.2.5.7. Belgium
      • 6.2.5.7.1. By Product
      • 6.2.5.7.2. By Technology
      • 6.2.5.7.3. By End User
      • 6.2.5.7.4. By Application
      • 6.2.5.8. NORDIC Countries
      • 6.2.5.8.1. By Product
      • 6.2.5.8.2. By Technology
      • 6.2.5.8.3. By End User
      • 6.2.5.8.4. By Application
      • 6.2.5.9. Rest of Europe
      • 6.2.5.9.1. By Product
      • 6.2.5.9.2. By Technology
      • 6.2.5.9.3. By End User
      • 6.2.5.9.4. By Application

7. Asia Pacific Molecular Diagnostics Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By End User
    • 7.2.4. By Application
    • 7.2.5. By Country
      • 7.2.5.1. China
      • 7.2.5.1.1. By Product
      • 7.2.5.1.2. By Technology
      • 7.2.5.1.3. By End User
      • 7.2.5.1.4. By Application
      • 7.2.5.2. India
      • 7.2.5.2.1. By Product
      • 7.2.5.2.2. By Technology
      • 7.2.5.2.3. By End User
      • 7.2.5.2.4. By Application
      • 7.2.5.3. Japan
      • 7.2.5.3.1. By Product
      • 7.2.5.3.2. By Technology
      • 7.2.5.3.3. By End User
      • 7.2.5.3.4. By Application
      • 7.2.5.4. South Korea
      • 7.2.5.4.1. By Product
      • 7.2.5.4.2. By Technology
      • 7.2.5.4.3. By End User
      • 7.2.5.4.4. By Application
      • 7.2.5.5. Australia & New Zealand
      • 7.2.5.5.1. By Product
      • 7.2.5.5.2. By Technology
      • 7.2.5.5.3. By End User
      • 7.2.5.5.4. By Application
      • 7.2.5.6. Indonesia
      • 7.2.5.6.1. By Product
      • 7.2.5.6.2. By Technology
      • 7.2.5.6.3. By End User
      • 7.2.5.6.4. By Application
      • 7.2.5.7. Malaysia
      • 7.2.5.7.1. By Product
      • 7.2.5.7.2. By Technology
      • 7.2.5.7.3. By End User
      • 7.2.5.7.4. By Application
      • 7.2.5.8. Singapore
      • 7.2.5.8.1. By Product
      • 7.2.5.8.2. By Technology
      • 7.2.5.8.3. By End User
      • 7.2.5.8.4. By Application
      • 7.2.5.9. Philippines
      • 7.2.5.9.1. By Product
      • 7.2.5.9.2. By Technology
      • 7.2.5.9.3. By End User
      • 7.2.5.9.4. By Application
      • 7.2.5.10. Vietnam
      • 7.2.5.10.1. By Product
      • 7.2.5.10.2. By Technology
      • 7.2.5.10.3. By End User
      • 7.2.5.10.4. By Application
      • 7.2.5.11. Rest of Asia Pacific
      • 7.2.5.11.1. By Product
      • 7.2.5.11.2. By Technology
      • 7.2.5.11.3. By End User
      • 7.2.5.11.4. By Application

8. Latin America Molecular Diagnostics Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By End User
    • 8.2.4. By Application
    • 8.2.5. By Country
      • 8.2.5.1. Brazil
      • 8.2.5.1.1. By Product
      • 8.2.5.1.2. By Technology
      • 8.2.5.1.3. By End User
      • 8.2.5.1.4. By Application
      • 8.2.5.2. Mexico
      • 8.2.5.2.1. By Product
      • 8.2.5.2.2. By Technology
      • 8.2.5.2.3. By End User
      • 8.2.5.2.4. By Application
      • 8.2.5.3. Argentina
      • 8.2.5.3.1. By Product
      • 8.2.5.3.2. By Technology
      • 8.2.5.3.3. By End User
      • 8.2.5.3.4. By Application
      • 8.2.5.4. Peru
      • 8.2.5.4.1. By Product
      • 8.2.5.4.2. By Technology
      • 8.2.5.4.3. By End User
      • 8.2.5.4.4. By Application
      • 8.2.5.5. Colombia
      • 8.2.5.5.1. By Product
      • 8.2.5.5.2. By Technology
      • 8.2.5.5.3. By End User
      • 8.2.5.5.4. By Application
      • 8.2.5.6. Rest of Latin America
      • 8.2.5.6.1. By Product
      • 8.2.5.6.2. By Technology
      • 8.2.5.6.3. By End User
      • 8.2.5.6.4. By Application

9. Middle East & Africa Molecular Diagnostics Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By End User
    • 9.2.4. By Application
    • 9.2.5. By Country
      • 9.2.5.1. Saudi Arabia
      • 9.2.5.1.1. By Product
      • 9.2.5.1.2. By Technology
      • 9.2.5.1.3. By End User
      • 9.2.5.1.4. By Application
      • 9.2.5.2. UAE
      • 9.2.5.2.1. By Product
      • 9.2.5.2.2. By Technology
      • 9.2.5.2.3. By End User
      • 9.2.5.2.4. By Application
      • 9.2.5.3. Qatar
      • 9.2.5.3.1. By Product
      • 9.2.5.3.2. By Technology
      • 9.2.5.3.3. By End User
      • 9.2.5.3.4. By Application
      • 9.2.5.4. Kuwait
      • 9.2.5.4.1. By Product
      • 9.2.5.4.2. By Technology
      • 9.2.5.4.3. By End User
      • 9.2.5.4.4. By Application
      • 9.2.5.5. Iran
      • 9.2.5.5.1. By Product
      • 9.2.5.5.2. By Technology
      • 9.2.5.5.3. By End User
      • 9.2.5.5.4. By Application
      • 9.2.5.6. South Africa
      • 9.2.5.6.1. By Product
      • 9.2.5.6.2. By Technology
      • 9.2.5.6.3. By End User
      • 9.2.5.6.4. By Application
      • 9.2.5.7. Nigeria
      • 9.2.5.7.1. By Product
      • 9.2.5.7.2. By Technology
      • 9.2.5.7.3. By End User
      • 9.2.5.7.4. By Application
      • 9.2.5.8. Kenya
      • 9.2.5.8.1. By Product
      • 9.2.5.8.2. By Technology
      • 9.2.5.8.3. By End User
      • 9.2.5.8.4. By Application
      • 9.2.5.9. Egypt
      • 9.2.5.9.1. By Product
      • 9.2.5.9.2. By Technology
      • 9.2.5.9.3. By End User
      • 9.2.5.9.4. By Application
      • 9.2.5.10. Morocco
      • 9.2.5.10.1. By Product
      • 9.2.5.10.2. By Technology
      • 9.2.5.10.3. By End User
      • 9.2.5.10.4. By Application
      • 9.2.5.11. Algeria
      • 9.2.5.11.1. By Product
      • 9.2.5.11.2. By Technology
      • 9.2.5.11.3. By End User
      • 9.2.5.11.4. By Application
      • 9.2.5.12. Rest of Middle East & Africa
      • 9.2.5.12.1. By Product
      • 9.2.5.12.2. By Technology
      • 9.2.5.12.3. By End User
      • 9.2.5.12.4. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Company Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, and others)

11. Impact of Covid-19 on Global Molecular Diagnostics Market Industry

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

  • 12.1. ABOTT LABORATORIES
  • 12.2. Agilent Technologies Inc.
  • 12.3. BECTON DICKINSON AND COMPANY
  • 12.4. BIOMERIEUX SA
  • 12.5. HOFFMON LA-ROCHE LTD
  • 12.6. GRIFOLS S.A.
  • 12.7. HOLOGIC INC.
  • 12.8. QIAGEN INC
  • 12.9. SIEMENS AG
  • 12.10. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations